0001140361-21-008338.txt : 20210312
0001140361-21-008338.hdr.sgml : 20210312
20210312163526
ACCESSION NUMBER: 0001140361-21-008338
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210308
FILED AS OF DATE: 20210312
DATE AS OF CHANGE: 20210312
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TOBIN JAMES R
CENTRAL INDEX KEY: 0001190128
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36200
FILM NUMBER: 21737960
MAIL ADDRESS:
STREET 1: C/O CURIS INC
STREET 2: 4 MAGUIRE ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oxford Immunotec Global PLC
CENTRAL INDEX KEY: 0001586049
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
BUSINESS PHONE: 44 01235 442780
MAIL ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
4
1
form4.xml
FORM 4
X0306
4
2021-03-08
true
0001586049
Oxford Immunotec Global PLC
OXFD
0001190128
TOBIN JAMES R
C/O OXFORD IMMUNOTEC GLOBAL PLC
94C INNOVATION DRIVE
ABINGDON, OXFORDSHIRE
X0
OX14 4RZ
UNITED KINGDOM
true
Ordinary Shares
2021-03-08
4
D
0
4081
22
D
0
D
Stock Option (Right to Buy)
8.65
2021-03-08
4
D
0
7457
13.35
D
2026-06-28
Ordinary Shares
7457
0
D
Stock Option (Right to Buy)
14.46
2021-03-08
4
D
0
7457
7.54
D
2027-06-06
Ordinary Shares
7457
0
D
Stock Option (Right to Buy)
14.49
2021-03-08
4
D
0
7457
7.51
D
2028-06-19
Ordinary Shares
7457
0
D
Stock Option (Right to Buy)
14.44
2021-03-08
4
D
0
7457
7.56
D
2029-06-18
Ordinary Shares
7457
0
D
Stock Option (Right to Buy)
13.02
2021-03-08
4
D
0
14914
8.98
D
2024-12-01
Ordinary Shares
14914
0
D
Stock Option (Right to Buy)
13.02
2021-03-08
4
D
0
7457
8.98
D
2024-12-01
Ordinary Shares
7457
0
D
Stock Option (Right to Buy)
14.17
2021-03-08
4
D
0
7457
7.83
D
2025-06-09
Ordinary Shares
7457
0
D
Stock Option (Right to Buy)
12.96
2021-03-08
4
D
0
9494
9.04
D
2030-06-24
Ordinary Shares
9494
0
D
Disposed pursuant to the acquisition by PerkinElmer (UK) Holdings Limited of the entire issued share capital of Oxford Immunotec Global PLC on March 8, 2021 by means of a scheme of arrangement under Part 26 of the Companies Act 2006 (the "Scheme").
In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price.
Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price.
/s/ Matthew T E McLaughlin, as Attorney-in-Fact for James R. Tobin
2021-03-12